Cell Source, Inc. (CLCS)

0.93 +0.13 (+16.25%) USD  |  OTCM  |  Apr 16, 16:00
More

Cell Source Return on Net Operating Assets (Annual)

Return on Net Operating Assets (Annual) Chart

View Return on Net Operating Assets (Annual) for CLCS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets (Annual) Range, Past 5 Years

View Return on Net Operating Assets (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets (Annual) Benchmarks

View Return on Net Operating Assets (Annual) Benchmarks
Start Trial
Celldex Therapeutics, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Atossa Therapeutics, Inc. Upgrade
Abeona Therapeutics, Inc. Upgrade
Kiora Pharmaceuticals, Inc. Upgrade